Acrow India Limited (ACROW.BO)
INR 848.95
(0.0%)
INR 848.95
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.31 Million | -10.06 Million | -6 Million | -6.36 Million | -6.49 Million | -1.26 Million |
| Net Income | 10.23 Million | -524 Thousand | 11.01 Million | -3.24 Million | -2.58 Million | 858 Thousand |
| Depreciation & Amortization | 2.99 Million | 1.8 Million | 2.41 Million | 2.4 Million | 2.74 Million | 3.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.42 Million | 1.51 Million | 8.62 Million | -1.88 Million | -1.14 Million | -1.61 Million |
| Other non-cash items | -1.94 Million | -12.86 Million | -28.05 Million | -3.63 Million | -5.5 Million | -3.81 Million |
| Investing Cash Flow | -8.5 Million | -61.39 Million | 20.18 Million | 4.09 Million | 7.93 Million | 6.63 Million |
| Investments in PPE | - | -871 Thousand | -2.05 Million | - | -159 Thousand | -180 Thousand |
| Acquisitions | 1.87 Million | - | 18 Million | - | 6.79 Million | 5.31 Million |
| Investment purchases | - | - | -73.54 Million | -88.75 Million | -249.22 Million | -252.28 Million |
| Sales/Maturities of investments | - | 94.5 Million | 81.45 Million | 96.13 Million | 250.52 Million | 163.18 Million |
| Other Investing Activities | -10.37 Million | -155.02 Million | -3.66 Million | -3.28 Million | 1000.00 | 90.6 Million |
| Financing Cash Flow | - | -5000.00 | -10 Thousand | -2000.00 | -490 Thousand | -1.01 Million |
| Debt repayment | - | - | - | - | -461 Thousand | -952 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -5.00 | -10.00 | -2.00 | -29 Thousand | -58 Thousand |
| Accounts receivables | - | 1.51 Million | -92 Thousand | -1.05 Million | -371 Thousand | 622 Thousand |
| Accounts payables | 597 Thousand | 56 Thousand | -161 Thousand | -53 Thousand | 130 Thousand | -433 Thousand |
| Inventory | - | - | 6.62 Million | - | 1000.00 | - |
| Other working capital | 1.83 Million | -58 Thousand | 2.24 Million | -781 Thousand | -908 Thousand | -1.8 Million |
| Cash at beginning of period | 295 Thousand | 71.75 Million | 57.58 Million | 59.84 Million | 58.9 Million | 54.54 Million |
| Cash at end of period | 188.15 Million | 295 Thousand | 71.75 Million | 57.58 Million | 59.84 Million | 58.9 Million |
| Capital Expenditure | - | -871 Thousand | -2.05 Million | - | -159 Thousand | -180 Thousand |
| Effect of forex changes on cash | - | - | - | 1000.00 | - | -1000.00 |
| Net cash flow / Change in cash | 187.86 Million | -71.46 Million | 14.17 Million | -2.26 Million | 945 Thousand | 4.36 Million |
| Free Cash Flow | 8.31 Million | -10.93 Million | -8.05 Million | -6.36 Million | -6.65 Million | -1.44 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1415.00 | 1944.00 | 10.23 Million | 3625.00 | 1837.00 | 2833.00 |
| Depreciation & Amortization | - | - | 2.99 Million | 793 Thousand | 987 Thousand | 444 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 2.42 Million | - | - | - |
| Other non-cash items | -1415.00 | -1944.00 | -1.94 Million | -3625.00 | -1837.00 | -2833.00 |
| Investing Cash Flow | - | - | -8.5 Million | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 1.87 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -10.37 Million | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | 597 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 1.83 Million | - | - | - |
| Cash at beginning of period | - | - | 295 Thousand | 82 Thousand | -1.75 Million | 295 Thousand |
| Cash at end of period | - | - | 188.15 Million | 1.66 Million | 82 Thousand | 2.83 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 187.86 Million | 1.58 Million | 1.83 Million | 2.53 Million |
| Free Cash Flow | - | - | 8.31 Million | 1.58 Million | 1.83 Million | 2.83 Million |
688070
BIOFILCHEM
LEOF
BFS-PE
SACH
CTL